JAK1 and anaplastic large cell lymphoma: Gain-of-function of Janus kinase 1 (JAK1) and the signal transducer and activator of transcription 3 (STAT3) mutations cause constitutive activation of the JAK-STAT pathway, which has been identified in approximately 18% of ALK-negative ALCL cases [58].